The data contains data dictionary, sociodemographic, clinical and laboratory datasets for healthcare workers and children in Zambia enrolled under pre-existing studies conducted in Kalulushi and Lusaka.
Sociodemographic and clinical data were obtained between September and November 2018 for children and during November through December 2019 fro healthcare workers.
SARS-CoV-2 anti-Spike S1 IgG sero-status was determined using an in-house developed ELISA assay on plasma samples obtained from both cohorts before the SARS-CoV-2 pandemic (2018-2019) and post the pandemic (August to December 2020)
Determination of SARS-CoV-2 exposure among these cohorts was approved by the National Health Research Authority in Zambia
Funding
Profiling innate and adaptive immune responses to rotavirus vaccination in Zambian infants